PROXIMA CLINICAL RESEARCH LAUNCHES NEW CAMPAIGN ENTITLED
“WE LOVE STARTUPS”
ALONG WITH AN EXPERT HELPDESK
A new chat feature that connects you directly to clinical and regulatory specialists
Houston, Texas: Today, on Valentine’s Day, Proxima Clinical Research, Inc., a leading provider of clinical and regulatory solutions, launched a year-long campaign focused on emerging biotech and medical device companies known as “We Love Startups.” Central to this launch is a sweepstakes giveaway valued at $20,000 for regulatory and clinical strategy and a new HelpDesk feature that allows companies with clinical, regulatory, or statistical analysis questions to engage with Proxima experts via an easy online chat.
Giveaway instructions can be found on the Proxima Clinical Research .LinkedIn page, and the HelpDesk is available on the Proxima website 24/7, with specific online office hours from 2-4pm every Tuesday, Wednesday and Thursday.
“Emerging companies face unique challenges. Large CROs are expensive, slow, and bureaucratic, leaving them ill-equipped to work with startups,” said Kevin Coker, CEO of Proxima and former McKesson Vice President. “Startups need a collaborative partner. They thrive off the free exchange of information and the need to move quickly with cost efficient solutions,” Mr. Coker added. “We listened closely to what companies wanted. This was the driver behind our HelpDesk, the first of its kind.”
Proxima plans on providing additional sweepstakes opportunities through 2019. Bookmark www.ProximaCRO.com and follow Proxima Clinical Research on LinkedIn for updates on new monthly opportunities.
About Proxima CRO: Proxima is a leading clinical research organization partnering with emerging companies to provide advisory and clinical development solutions. Proxima provides services across the board from early stage strategy through post-approval supplements. Guided by the principles of agile management, Proxima successfully provides the best solutions for emerging companies in medtech and biotech industry.
Proxima Clinical Research, Inc.